Product description:


Lactovaginal® is the most commonly selected vaginal gynaecological probiotic, enjoying long-term trust of patients and physicians, and characterised by a high safety profile.

Lactobacillus rhamnosus 573 bacteria included in Lactovaginal® produce lactic acid which maintains the proper pH of the vagina, protecting against the development of pathogenic bacteria. L. rhamnosus 573 bacilli demonstrate antagonism against the majority of bacteria that cause urogenital infections.

Clinical trials have shown that Lactovaginal® use after the treatment of vaginal inflammations results in: a reduction in the number of pathogens, restoring the natural microbiological balance of the vagina and normalizing vaginal secretions.



1 capsule contains Lactobacillus rhamnosus 573 bacilli, approximately 1010, including not less than 108 CFU (colony forming units).

Instructions of use

Lactovaginal® is recommended for the restoration or supplementation of the normal bacterial flora of the vagina: in inflammatory conditions of the reproductive organs after treatment with antibacterial, antitrichomonal or antifungal drugs, in the presence of vaginal discharge as well as prophylactically.


Hypersensitivity to the active substance or to any of the excipients.


From 1 to 2 capsules a day (one in the morning and one at night) for 1 week. The treatment can be repeated when necessary.


1 blister, 10 vaginal capsules each.

Expiration date

2 years.


Store in a refrigerator at 2°C – 8°C. During the shelf-life period, the medicine can be stored outside the refrigerator at 25˚C for 4 weeks.

Pharmaceutical form

Vaginal capsule, hard.


OTC drug, issued without a prescription.

Product website

Legal information

Before using, read the leaflet, which contains indications, contraindications, data on adverse reactions and dosage, as well as information on the use of the medicinal product, or consult with a doctor or pharmacist as any drug used improperly poses a threat to your life or health.

Responsible entity and manufacturer:

Instytut Biotechnologii Surowic i Szczepionek BIOMED Spółka Akcyjna, Al. Sosnowa 8, 30-224 Kraków, Poland.

Phone: +48 12 37 69 200, Fax: +48 12 37 69 205

The page you are visiting makes use of cookies. Settings for these files can be changed in the options of browser used to browse the Internet. If you want to learn more about cookies files read the Privacy Policy.


If cookie settings are not changed, while browsing the site information will be automatically stored in the memory of your device. Do not show this message again: click here.